NAD+ levels are impacted by a variety of factors including lifestyle (e.g. smoking, alcohol consumption, sleep), aging and certain chronic conditions. This article will look at some of the most common conditions associated with NAD+ deficiencies and how NAD+ supplements such as Nuchido TIME+ can benefit these patients.
While the aetiology of chronic fatigue syndrome (CFS) is not fully understood, there are several cellular changes that are routinely seem in CFS patients. These include:
- Mitochondrial dysfunction and impaired energy metabolism
- Increased oxidative stress
- Increased expression of pro-inflammatory factors
- Cognitive impairment (‘brain fog’)
- Reduced immune function
It is now known that many of these cellular processes are dependent on NAD+ and increasing cellular NAD+ levels may help to alleviate symptoms in CFS patients.
For example, adequate NAD+ levels are critical for normal mitochondrial function. During the production of ATP, NAD+ acts as an electron donor / acceptor and therefore its loss impairs cellular energy production, contributing to fatigue.
NAD+ and the sirtuins also work together to maintain mitochondrial health by activating proteins which regulate mitochondrial biogenesis, mitophagy, and antioxidant pathways (e.g. PGC-1α, FOXO). The loss of NAD+/Sirtuins increases the production of free radicals, leading to mitochondrial damage and dysfunction, which has been linked to other classic symptoms of CFS such as brain fog.
NAD+ and the Sirtuins are also involved in regulating circadian rhythm. The production of many hormones, metabolites, and NAD+ itself are linked to the circadian rhythm. Therefore, loss of NAD+ disrupts this rhythm further contributing to fatigue symptoms.
It is now clear that increasing NAD+ levels is beneficial against many symptoms of CFS.
The average age a woman enters menopause is 51 and by this time her NAD+ levels will have declined drastically. The loss of estrogen and NAD+ combined creates a perfect storm for cellular dysfunction.
Some of the most of common symptoms experienced during menopause are linked to estrogen and NAD+ decline:
- Reduced energy levels – both NAD+ and estrogen contribute to mitochondrial function and normal energy production. During menopause, levels of these molecules become low leading to reduced energy production. By increasing NAD+, ATP production is increased, supporting optimal mitochondrial function and energy production.
- Brain fog – estrogen has neuroprotective functions; loss of estrogen impairs ATP production in neurons but also the function of key brain regions such as the hippocampus and the frontal lobe. NAD+ dependent enzymes are involved in synaptic plasticity and neuronal stress resistance and loss of NAD+ contributes to brain aging. Recent studies are investigating NAD+ therapy for neurodegenerative diseases.
- Accelerated biological aging – hormones are important in regulating biological age (the rate at which cells are aging and functioning), with recent studies showing that peri/menopause can accelerate aging and rapidly increase a woman’s biological age. NAD+ is known to promote youthful cellular function and reverse biological age.
Inflammation is beneficial for short periods of time in response to infection, injury, or wound healing, however, long term chronic inflammation which occurs during aging and in certain diseases can accelerate aging and is damaging to organs and tissues.
NAD+ via sirtuins activation mediates immune cell function and suppresses chronic inflammation. Sirtuins suppress NF-κβ which prevents aberrant expression of pro-inflammatory cytokines such as IL-6, IL-10 and TNF-α.
Interestingly, excessive inflammation depletes NAD+ levels. This is because inflammation increases the number of senescent cells in the body which in turn increases expression of the ectoenzyme CD38, which is the largest NAD+ consumer, therefore depleting NAD+ and causing further inflammation.
Post-Acute COVID-19 Syndrome
Those most susceptible to infection by viruses particularly COVID-19 are older individuals and those with co-morbidities. This is because they have reduced immune function which has been linked to reduced levels of cellular NAD+.
Recent studies investigating Post-Acute COVID-19 Syndrome (PACS) suggest that NAD+ supplements can be beneficial for these patients. This is because COVID-19 depletes NAD+ levels to support its own replication. COVID-19 creates a highly inflammatory environment within cells, via overactivation of T-cells, this causes overactivation of PARP1 which drains cellular NAD+ and ATP levels. Leaving many critical cellular repair processes without sufficient NAD+ contributing to COVID-19 and PACS symptoms.
Replenishment of cellular NAD+ levels is being tested to enhance the antiviral capabilities of cells and suppress uncontrolled inflammation.
Overall, NAD+ has many vital functions and NAD+ deficiencies are seen in a variety of conditions. Current knowledge of NAD+ suggests it may have particular therapeutic benefits for those with CFS, menopause, chronic inflammation and PACS.